Efficacy of Intravenous Ibuprofen Compared to Intravenous Ketorolac for Pain Control Following Arthroscopic Knee Surgery
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01901393 |
Recruitment Status :
Completed
First Posted : July 17, 2013
Results First Posted : February 15, 2016
Last Update Posted : March 14, 2016
|
Sponsor:
Cumberland Pharmaceuticals
Information provided by (Responsible Party):
Cumberland Pharmaceuticals
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Study Type | Interventional |
---|---|
Study Design | Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Triple (Participant, Care Provider, Investigator); Primary Purpose: Treatment |
Condition |
Pain |
Interventions |
Drug: IV ibuprofen Drug: Ketorolac |
Enrollment | 100 |
Participant Flow
Baseline Characteristics
Outcome Measures
Adverse Events
Limitations and Caveats
[Not Specified]
More Information
Results Point of Contact
Name/Title:
Amy Rock, PhD
Organization:
Cumberland Pharmaceutical Inc.
Phone:
615-255-0068
EMail:
arock@cumberlandpharma.com
Responsible Party: | Cumberland Pharmaceuticals |
ClinicalTrials.gov Identifier: | NCT01901393 History of Changes |
Other Study ID Numbers: |
CPI-CL-020 |
First Submitted: | July 12, 2013 |
First Posted: | July 17, 2013 |
Results First Submitted: | January 18, 2016 |
Results First Posted: | February 15, 2016 |
Last Update Posted: | March 14, 2016 |